Related Experiment Video
Updated: Oct 19, 2025
09:25
Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
11.6K
Supporting tobacco cessation in tuberculosis patients
Omara Dogar1, Aishwarya Vidyasagaran2
1University of York, Department of Health Sciences, YO10 5DD, York, United Kingdom; The University of Edinburgh, Usher Institute, EH8 9AG, Edinburgh, United Kingdom.
The Indian Journal of Tuberculosis
|September 20, 2021
Summary
Tobacco use worsens health inequalities and tuberculosis (TB) outcomes, especially in low-income countries. Integrating smoking cessation interventions into TB care is crucial for better patient results and achieving global health goals.
Area of Science:
- Public Health
- Global Health
- Epidemiology
Background:
- Tobacco use is a significant driver of health disparities globally, disproportionately affecting low-income nations with high tuberculosis (TB) burdens.
- Tuberculosis disproportionately impacts low-income populations, which also exhibit higher smoking rates, leading to poorer treatment outcomes for TB patients who smoke.
Discussion:
- Behavioral interventions effectively promote smoking cessation in TB patients by influencing health beliefs and attitudes.
- Integrating these successful interventions into routine TB care presents significant challenges, necessitating cultural and organizational changes at multiple levels.
Key Insights:
- Addressing the dual burden of tobacco use and TB requires a multi-faceted approach involving policy, practice, and research.
- Smoking cessation support is vital for improving treatment outcomes in tuberculosis patients.
Outlook:
- Implementing policy and practice recommendations is essential for tackling the co-epidemics of tobacco use and TB.
- Action is critical to meet the United Nations Sustainable Development Goal (SDG) target of ending the TB epidemic by 2030.
Related Concept Videos
01:28Pulmonary Tuberculosis V
269
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
269
01:29Pulmonary Tuberculosis I
419
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
419
01:28Pulmonary Tuberculosis II
674
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
674
01:31Pulmonary Tuberculosis III
527
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
527
01:26Pulmonary Tuberculosis IV
236
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
236
01:17Other Pulmonary Disorders
1.0K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.0K